Heartflow, Inc. Common Stock HTFL NASDAQ

Heartflow, Inc. Common Stock (HTFL) reported total assets of $359.45M and total liabilities of $58.81M for fiscal year 2025, resulting in total equity of $300.65M.

The company held $176.79M in cash and short-term investments. Total debt stood at $22.05M, with net debt of $-22.72M. The Debt-to-Equity (D/E) ratio was 0.07 (conservative).

Current ratio is 5.2, indicating strong short-term liquidity. Interest coverage is -4.2x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (70/100) — Total assets $359.45M and equity $300.65M support the company's competitive scale
• VALUE (58/100) — Debt-to-Equity 0.07 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.

LEGN

Legend Biotech Corporation

$20.52

+9.79%

TVTX

Travere Therapeutics, Inc.

$40.95

-2.80%

LIVN

LivaNova PLC

$65.14

+0.23%

TARS

Tarsus Pharmaceuticals, Inc.

$71.80

-2.72%

PRVA

Privia Health Group, Inc.

$23.44

+1.38%

IRON

Disc Medicine, Inc.

$70.18

-0.43%

ZLAB

Zai Lab Limited

$23.25

+5.87%

ATEC

Alphatec Holdings, Inc.

$11.42

-0.87%